Literature DB >> 23766260

Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.

Aaron Isaacs1, Sara M Willems, Daniel Bos, Abbas Dehghan, Albert Hofman, M Arfan Ikram, André G Uitterlinden, Ben A Oostra, Oscar H Franco, Jacqueline C Witteman, Cornelia M van Duijn.   

Abstract

OBJECTIVE: Circulating levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, and triglycerides are recognized risk factors for cardiovascular disease. We tested the hypothesis that the cumulative effects of common genetic variants for lipids are collectively associated with subclinical atherosclerosis and incident coronary heart disease. APPROACH AND
RESULTS: Participants were drawn from the Erasmus Rucphen Family Study (n=2269) and the Rotterdam Study (n=8130). Linear regression and Cox proportional hazards models were applied to assess the influence of 4 risk scores derived from common genetic variants for lipids (total cholesterol, LDL-C, high-density lipoprotein cholesterol, and triglycerides) on carotid plaque, intima-media thickness, incident myocardial infarction, and coronary heart disease. Adjusted for age and sex, all 4 risk scores were associated with carotid plaque. This relationship was the strongest for the LDL-C score, which increased plaque score by 0.102 per SD increase in genetic risk score (P=3.2 × 10(-8)). The LDL-C score was also nominally associated with intima-media thickness, which increased 0.006 mm per SD increase in score (P=0.05). Both the total cholesterol and LDL-C scores were associated with incident myocardial infarction and coronary heart disease with hazard ratios between 1.10 and 1.13 per SD increase in score. Inclusion of additional risk factors as covariates minimally affected these results.
CONCLUSIONS: Common genetic variants with small effects on lipid levels are, in combination, significantly associated with subclinical and clinical cardiovascular outcomes. As knowledge of genetic variation increases, preclinical genetic screening tools might enhance the prediction and prevention of clinical events.

Entities:  

Keywords:  atherosclerosis; carotid artery plaque; carotid intima-media thickness; coronary disease; genetic screening; lipids; myocardial infarction

Mesh:

Substances:

Year:  2013        PMID: 23766260     DOI: 10.1161/ATVBAHA.113.301236

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.

Authors: 
Journal:  Diabetologia       Date:  2015-05-14       Impact factor: 10.122

2.  Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids.

Authors:  Aseel AlSaleh; Zoitsa Maniou; Fiona J Lewis; Wendy L Hall; Thomas A B Sanders; Sandra D O'Dell
Journal:  Genes Nutr       Date:  2014-06-03       Impact factor: 5.523

3.  A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis.

Authors:  Rector Arya; Agustin Escalante; Vidya S Farook; Jose F Restrepo; Daniel F Battafarano; Marcio Almeida; Mark Z Kos; Marcel J Fourcaudot; Srinivas Mummidi; Satish Kumar; Joanne E Curran; Christopher P Jenkinson; John Blangero; Ravindranath Duggirala; Inmaculada Del Rincon
Journal:  Atherosclerosis       Date:  2017-11-26       Impact factor: 5.162

Review 4.  Systems Biology and Noninvasive Imaging of Atherosclerosis.

Authors:  Claudia Calcagno; Willem J M Mulder; Matthias Nahrendorf; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02       Impact factor: 8.311

5.  Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.

Authors:  Jing-Zhan Zhang; Xiang Xie; Yi-Tong Ma; Ying-Ying Zheng; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Chuan-Fang Dai; Ming-Ming Zhang; Guo-Ting Yin; Fen Liu; Bang-Dang Chen; Min-Tao Gai
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

Review 6.  Genetics of coronary artery disease and myocardial infarction.

Authors:  Xuming Dai; Szymon Wiernek; James P Evans; Marschall S Runge
Journal:  World J Cardiol       Date:  2016-01-26

Review 7.  Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes.

Authors:  Jennifer A Smith; Erin B Ware; Pooja Middha; Lisa Beacher; Sharon L R Kardia
Journal:  Curr Epidemiol Rep       Date:  2015

Review 8.  Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants.

Authors:  Sergi Sayols-Baixeras; Carla Lluís-Ganella; Gavin Lucas; Roberto Elosua
Journal:  Appl Clin Genet       Date:  2014-01-16

9.  Association of common genetic variants with lipid traits in the Indian population.

Authors:  Gagandeep Kaur Walia; Vipin Gupta; Aastha Aggarwal; Mohammad Asghar; Frank Dudbridge; Nicholas Timpson; Nongmaithem Suraj Singh; M Ravi Kumar; Sanjay Kinra; Dorairaj Prabhakaran; K Srinath Reddy; Giriraj Ratan Chandak; George Davey Smith; Shah Ebrahim
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  Blood lipids and prostate cancer: a Mendelian randomization analysis.

Authors:  Caroline J Bull; Carolina Bonilla; Jeff M P Holly; Claire M Perks; Neil Davies; Philip Haycock; Oriana Hoi Yun Yu; J Brent Richards; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Robert J MacInnis; Fredrik Wiklund; Henrik Gronberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; David Neal; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Agnieszka Micheal; Hardev Pandha; George Davey Smith; Sarah J Lewis; Richard M Martin
Journal:  Cancer Med       Date:  2016-03-19       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.